BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 31640630)

  • 1. Immunoreactive trypsinogen levels in newborn screened infants with an inconclusive diagnosis of cystic fibrosis.
    Ooi CY; Sutherland R; Castellani C; Keenan K; Boland M; Reisman J; Bjornson C; Chilvers MA; van Wylick R; Kent S; Price A; Mateos-Corral D; Hughes D; Solomon M; Zuberbuhler P; Brusky J; Durie PR; Ratjen F; Gonska T
    BMC Pediatr; 2019 Oct; 19(1):369. PubMed ID: 31640630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cystic Fibrosis Transmembrane Conductance Regulator-Related Metabolic Syndrome and Cystic Fibrosis Screen Positive, Inconclusive Diagnosis.
    Ren CL; Borowitz DS; Gonska T; Howenstine MS; Levy H; Massie J; Milla C; Munck A; Southern KW
    J Pediatr; 2017 Feb; 181S():S45-S51.e1. PubMed ID: 28129812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A survey of the prevalence, management and outcome of infants with an inconclusive diagnosis following newborn bloodspot screening for cystic fibrosis (CRMS/CFSPID) in six Italian centres.
    Terlizzi V; Claut L; Tosco A; Colombo C; Raia V; Fabrizzi B; Lucarelli M; Angeloni A; Cimino G; Castaldo A; Marsiglio L; Timpano S; Cirilli N; Moroni L; Festini F; Piccinini P; Zavataro L; Bonomi P; Taccetti G; Southern KW; Padoan R
    J Cyst Fibros; 2021 Sep; 20(5):828-834. PubMed ID: 33883100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoreactive trypsinogen in healthy newborns and infants with cystic fibrosis.
    Fingerhut R; Rueegg CS; Imahorn O; Pedersen ESL; Kuehni CE; Gallati S; Regamey N; Barben J
    Arch Dis Child Fetal Neonatal Ed; 2023 Mar; 108(2):176-181. PubMed ID: 36351789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of children with cystic fibrosis screen positive, inconclusive diagnosis/CFTR related metabolic syndrome.
    Gunnett MA; Baker E; Mims C; Self ST; Gutierrez HH; Guimbellot JS
    Front Pediatr; 2023; 11():1127659. PubMed ID: 36969284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gradual increase in sweat chloride concentration is associated with a higher risk of CRMS/CFSPID to CF reclassification.
    Salinas DB; Ginsburg DK; Wee CP; Saeed MM; Brewington JJ
    Pediatr Pulmonol; 2023 Apr; 58(4):1074-1084. PubMed ID: 36582049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cystic fibrosis newborn screening in Denmark: Experience from the first 2 years.
    Skov M; Baekvad-Hansen M; Hougaard DM; Skogstrand K; Lund AM; Pressler T; Olesen HV; Duno M
    Pediatr Pulmonol; 2020 Feb; 55(2):549-555. PubMed ID: 31682332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotype of children with inconclusive cystic fibrosis diagnosis after newborn screening.
    Munck A; Bourmaud A; Bellon G; Picq P; Farrell PM;
    Pediatr Pulmonol; 2020 Apr; 55(4):918-928. PubMed ID: 31916691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoreactive Trypsinogen in Infants Born to Women with Cystic Fibrosis Taking Elexacaftor-Tezacaftor-Ivacaftor.
    Patel P; Yeley J; Brown C; Wesson M; Lesko BG; Slaven JE; Chmiel JF; Jain R; Sanders DB
    Int J Neonatal Screen; 2023 Feb; 9(1):. PubMed ID: 36975847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cystic fibrosis screen positive inconclusive diagnosis (CFSPID): Experience in Tuscany, Italy.
    Terlizzi V; Mergni G; Buzzetti R; Centrone C; Zavataro L; Braggion C
    J Cyst Fibros; 2019 Jul; 18(4):484-490. PubMed ID: 31005549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inconclusive diagnosis of cystic fibrosis after newborn screening.
    Ooi CY; Castellani C; Keenan K; Avolio J; Volpi S; Boland M; Kovesi T; Bjornson C; Chilvers MA; Morgan L; van Wylick R; Kent S; Price A; Solomon M; Tam K; Taylor L; Malitt KA; Ratjen F; Durie PR; Gonska T
    Pediatrics; 2015 Jun; 135(6):e1377-85. PubMed ID: 25963003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical outcomes in infants with cystic fibrosis transmembrane conductance regulator (CFTR) related metabolic syndrome.
    Ren CL; Desai H; Platt M; Dixon M
    Pediatr Pulmonol; 2011 Nov; 46(11):1079-84. PubMed ID: 21538969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Pancreatitis-Associated Protein on Newborn Screening Outcomes and Detection of CFTR-Related Metabolic Syndrome (CRMS)/Cystic Fibrosis Screen Positive, Inconclusive Diagnosis (CFSPID): A Monocentric Prospective Pilot Experience.
    Bianchimani C; Dolce D; Centrone C; Campana S; Ravenni N; Orioli T; Camera E; Mergni G; Fevola C; Bonomi P; Taccetti G; Terlizzi V
    Int J Neonatal Screen; 2022 Aug; 8(3):. PubMed ID: 35997436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cystic fibrosis screen positive, inconclusive diagnosis.
    Barben J; Southern KW
    Curr Opin Pulm Med; 2016 Nov; 22(6):617-22. PubMed ID: 27583671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initial evaluation of a biochemical cystic fibrosis newborn screening by sequential analysis of immunoreactive trypsinogen and pancreatitis-associated protein (IRT/PAP) as a strategy that does not involve DNA testing in a Northern European population.
    Sommerburg O; Lindner M; Muckenthaler M; Kohlmueller D; Leible S; Feneberg R; Kulozik AE; Mall MA; Hoffmann GF
    J Inherit Metab Dis; 2010 Oct; 33(Suppl 2):S263-71. PubMed ID: 20714932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Updated guidance on the management of children with cystic fibrosis transmembrane conductance regulator-related metabolic syndrome/cystic fibrosis screen positive, inconclusive diagnosis (CRMS/CFSPID).
    Barben J; Castellani C; Munck A; Davies JC; de Winter-de Groot KM; Gartner S; Kashirskaya N; Linnane B; Mayell SJ; McColley S; Ooi CY; Proesmans M; Ren CL; Salinas D; Sands D; Sermet-Gaudelus I; Sommerburg O; Southern KW;
    J Cyst Fibros; 2021 Sep; 20(5):810-819. PubMed ID: 33257262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different management approaches and outcome for infants with an inconclusive diagnosis following newborn screening for cystic fibrosis (CRMS/CFSPID) and Pseudomonas aeruginosa isolation.
    Dolce D; Claut L; Colombo C; Tosco A; Castaldo A; Padoan R; Timpano S; Fabrizzi B; Bonomi P; Taccetti G; Terlizzi V
    J Cyst Fibros; 2023 Jan; 22(1):73-78. PubMed ID: 35869019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A survey of newborn screening for cystic fibrosis in Europe.
    Southern KW; Munck A; Pollitt R; Travert G; Zanolla L; Dankert-Roelse J; Castellani C;
    J Cyst Fibros; 2007 Jan; 6(1):57-65. PubMed ID: 16870510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High rates of anxiety detected in mothers of children with inconclusive cystic fibrosis screening results.
    Ginsburg DK; Salinas DB; Cosanella TM; Wee CP; Saeed MM; Keens TG; Gold JI
    J Cyst Fibros; 2023 May; 22(3):420-426. PubMed ID: 36528525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cystic fibrosis transmembrane conductance regulator-related metabolic syndrome/cystic fibrosis screen positive, inconclusive diagnosis (CRMS/CFSPID).
    Sinha A; Southern KW
    Breathe (Sheff); 2021 Sep; 17(3):210088. PubMed ID: 35035555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.